Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions
Le Guo, Yaxian Zhou, Xueqing Nie, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114317-114317
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Chemistries of bifunctional PROTAC degraders
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 170
Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1269-1284
Open Access | Times Cited: 89
Advancing Strategies for Proteolysis-Targeting Chimera Design
Minglei Li, Ying Zhi, Bo Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2308-2329
Closed Access | Times Cited: 46
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Current advances and development strategies of orally bioavailable PROTACs
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 35
Innovative, combinatorial and high-throughput approaches to degrader synthesis
Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4838-4861
Closed Access | Times Cited: 9
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs
Irene Preet Bhela, Alice Ranza, Federica Carolina Balestrero, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 22, pp. 15282-15299
Open Access | Times Cited: 34
Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACs
Rebecca Stevens, Enrique Bendito-Moll, David Battersby, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15437-15452
Closed Access | Times Cited: 18
Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction Mixtures
Mateusz P. Plesniak, Emilia K. Taylor, Frederik Eisele, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1882-1890
Closed Access | Times Cited: 18
Accelerating PROTACs Discovery Through a Direct‐to‐Biology Platform Enabled by Modular Photoclick Chemistry
Ke‐Nian Yan, Yong‐Qiang Nie, Jiayu Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 7
Reversible Assembly of Proteolysis Targeting Chimeras
Weijun Gui, Sarah F. Giardina, Madeline Balzarini, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 7, pp. 1582-1593
Closed Access | Times Cited: 16
Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery
Zefeng Wang, Shabnam Shaabani, Xiang Gao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Development of Potent and Selective Coactivator-Associated Arginine Methyltransferase 1 (CARM1) Degraders
Haibo Xie, Megan Bacabac, M Ma, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 13028-13042
Open Access | Times Cited: 12
Development of Oligomeric Mannose-6-phosphonate Conjugates for Targeted Protein Degradation
Christopher Μ. Stevens, Yaxian Zhou, Peng Teng, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 719-726
Open Access | Times Cited: 11
PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications
Narayanaperumal Pravin, Krzysztof Jóźwiak
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116837-116837
Open Access | Times Cited: 4
Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC
Jiexuan Chen, Mingfei Wu, Jun Mo, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Factors to Consider for Synthesis in 1536-Well Plates─An Amide Coupling Case Study for PROTAC Synthesis
Rebecca Stevens, Harry E. P. Palmer, Afjal H. Miah, et al.
The Journal of Organic Chemistry (2025)
Open Access
Targeted Protein Degradation: From Basic Science to Therapeutic Applications
R Zhu, Xiaoyu Tang, Heng Zhang
ACS Chemical Biology (2025)
Closed Access
A comprehensive review of BET-targeting PROTACs for cancer therapy
Xiaoli Zhou, Fang Zhao, Yong-Tao Xu, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117033-117033
Closed Access | Times Cited: 17
Next steps for targeted protein degradation
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 3
A platform for the rapid synthesis of molecular glues (Rapid-Glue) under miniaturized conditions for direct biological screening
Jingyao Li, Chunrong Li, Zhongrui Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115567-115567
Open Access | Times Cited: 9
A practical “preTACs-cytoblot” platform accelerates the streamlined development of PROTAC-based protein degraders
Zijian Rao, Kailin Li, Ju-Eun Hong, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115248-115248
Closed Access | Times Cited: 7
Bifunctional robots inducing targeted protein degradation
M. Elizabeth Sobhia, Harish Kumar, Sonia Kumari
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115384-115384
Closed Access | Times Cited: 7
Late-stage synthesis of heterobifunctional molecules for PROTAC applications via ruthenium-catalysed C‒H amidation
Daniele Antermite, Stig D. Friis, Johan R. Johansson, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Applications and Limitations of Oxime‐Linked “Split PROTACs”
Weijun Gui, Thomas Kodadek
ChemBioChem (2022) Vol. 23, Iss. 18
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top